Abstract
It is necessary to use more effective and safer therapies to treat the increasing prevalence of metabolic diseases. The evidence from several studies indicates that FGF21 which acts as an endocrine hormone can induce beneficial influence to metabolism without apparent adverse effects. Thus, the pharmacologic and physiologic actions of FGF21 play a key role in controlling substrate utilization and energy balance. Recently, the developments in the understanding of FGF21 have contributed to make FGF21 a viable and promising therapeutic agent. This review discusses the functions of FGF21 in the high-fat-diet response, the relationship between exercise and the expression of FGF21, the interaction between FGF21 and some important hormone, the potential of FGF21 pharmacology in human and the methods to prolong the half-life of FGF21. These perspectives about FGF21’s therapeutic potential highlight the importance of this molecule which could be a novel and attractive drug for metabolism disorder.
Keywords: Exercise, fibroblast growth factor 21, half-life, high-fat-diet, hormone, metabolism, pharmacology, therapeutic agent.
Current Pharmaceutical Design
Title:Multiple Roles of Fibroblast Growth Factor 21 in Metabolism
Volume: 21 Issue: 21
Author(s): L i Li and Liling Tang
Affiliation:
Keywords: Exercise, fibroblast growth factor 21, half-life, high-fat-diet, hormone, metabolism, pharmacology, therapeutic agent.
Abstract: It is necessary to use more effective and safer therapies to treat the increasing prevalence of metabolic diseases. The evidence from several studies indicates that FGF21 which acts as an endocrine hormone can induce beneficial influence to metabolism without apparent adverse effects. Thus, the pharmacologic and physiologic actions of FGF21 play a key role in controlling substrate utilization and energy balance. Recently, the developments in the understanding of FGF21 have contributed to make FGF21 a viable and promising therapeutic agent. This review discusses the functions of FGF21 in the high-fat-diet response, the relationship between exercise and the expression of FGF21, the interaction between FGF21 and some important hormone, the potential of FGF21 pharmacology in human and the methods to prolong the half-life of FGF21. These perspectives about FGF21’s therapeutic potential highlight the importance of this molecule which could be a novel and attractive drug for metabolism disorder.
Export Options
About this article
Cite this article as:
Li i L and Tang Liling, Multiple Roles of Fibroblast Growth Factor 21 in Metabolism, Current Pharmaceutical Design 2015; 21 (21) . https://dx.doi.org/10.2174/1381612821666150212155239
DOI https://dx.doi.org/10.2174/1381612821666150212155239 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mechanisms of Cardiovascular Changes in an Experimental Model of Syndrome X and Pharmacological Intervention on the Renin-Angiotensin- System
Current Vascular Pharmacology Estrogen Receptors as Targets for Drug Development for Breast Cancer, Osteoporosis and Cardiovascular Diseases
Current Cancer Drug Targets Biomarkers for Risk Assessment and Prevention of Breast Cancer
Current Cancer Drug Targets Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets Evaluating 3D-printed Bolus Compared to Conventional Bolus Types Used in External Beam Radiation Therapy
Current Medical Imaging Stress and Vulnerability Due to the Care Task: An Observational Study on Older Caregivers
Current Psychopharmacology Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
Current Medicinal Chemistry Role of Vascular Progenitor Cells in Cardiovascular Disease
Current Pharmaceutical Design Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
Current Vascular Pharmacology The Current Role of Statin Therapy in the Treatment of Atrial Fibrillation
Cardiovascular & Hematological Agents in Medicinal Chemistry Biological Ageing, Inflammation and Nutrition: How Might They Impact on Systemic Sclerosis?
Current Aging Science Environmental Pollution and Diabetes Mellitus
Recent Patents on Biomarkers Leukocyte P2 Receptors: A Novel Target for Anti-inflammatory and Antitumor Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders An Insight into the Recent Diabetes Trials: What is the Best Approach to Prevent Macrovascular and Microvascular Complications?
Current Diabetes Reviews Statin Therapy-Evidence Beyond Lipid Lowering Contributing to Plaque Stability
Current Medicinal Chemistry Inflammation in Fish As Seen from A Morphological Point of View with Special Reference to the Vascular Compartment
Current Pharmaceutical Design Detection of Biothiols Using Some Novel Chemosensors: An Overview
Mini-Reviews in Organic Chemistry Determinants of the Resolution of Type 2 Diabetes After Bariatric Surgery
Vascular Disease Prevention (Discontinued) Effects of ACE Inhibitors on Skeletal Muscle
Current Pharmaceutical Design Therapeutic Targeting of HDL and Reverse Cholesterol Transport
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents